The SOUL protocol had participants randomized 1:1 to oral semaglutide (starting at 3 mg and escalated to 14 mg for the rest of the study) or placebo. Participants were told to take their assigned ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...

Tablets of semaglutide (currently sold in injectable form as Wegovy for obesity and Ozempic for diabetes), made by the Danish firm Novo Nordisk, could reach the UK as early as next year.

[i] Rybelsus (semaglutide) tablets are FDA-approved for oral use and were not in shortage. The FDA’s February Declaratory order specifically addresses the compounding of semaglutide injection ...

The FBI says counterfeit versions of the drugs can cause health issues. The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. Research has revealed additional ...

People taking semaglutide drugs like Ozempic typically expect to lose excess weight — not hair. But that’s precisely what happened to Desiree Rodriguez, who has been sharing her journey on ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

Researchers believe that Semaglutide shows promise in cutting the risk of conditions that could impair memory and thought ...

Studies show promising results for semaglutide as a potential treatment for alcohol use disorder. Semaglutide, a GLP-1 drug, was initially used for type 2 diabetes treatment and weight loss.